Lumicell is changing the landscape of cancer surgery with a hand-held imaging system that will give surgeons real-time feedback about whether any cancer is left behind in the tumor bed following initial tumor resection.
Lumicell is addressing the number one challenge in cancer surgery – the need to remove all cancer cells during the first surgery.
Lumicell Successfully Completes Phase 2a Feasibility Study -- Lumicell has announced it successfully completed its Phase 2a feasibility study on the Company’s groundbreaking LUM Imaging System
Lumicell Publishes Data Supporting LUM015, Fluorescent Probe for Imaging Cancer, in Science Translational Medicine -- Lumicell has announced the publication of research supporting the Company’s groundbreaking protease-activated fluorescent imaging probe, LUM015, in Science Translational Medicine.
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer Science Translational Medicine 06 Jan 2016: Vol. 8, Issue 320, pp. 320ra4 DOI: 10.1126/scitranslmed.aad0293